With established experience in the pharmaceuticals industry, Boyanov & Co. continues to advise healthcare and life sciences clients on intellectual property matters including protection, prosecution and enforcement of IP rights. The group also advises on pharmaceutical antitrust, patent litigation and both local and EU regulatory matters. As a former judge, Kina Chuturkova stands out for her work in litigation and international arbitration proceedings, and leads the team along with Peter Petrov, who is well-versed in day-to-day regulatory matters for pharmaceutical clients. Another active member of the group is Nedyalka Novakova, who is geared to support on contractual issues and IP issues in the healthcare space.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- Peter Petrov consistently demonstrates an exceptional level of professionalism, expertise, and dedication that sets him apart from competitors. Peter’s deep understanding of both local regulations and the broader business context enables him to provide strategic, practical advice tailored to our needs. He is proactive, responsive, and always willing to go the extra mile to ensure our interests are protected. What truly distinguishes Peter is his attention to detail, clear communication, and ability to anticipate potential challenges before they arise. He is not only technically proficient but also highly collaborative, making complex legal matters accessible and manageable for our team. Peter’s reliability, integrity, and commitment to delivering results have made him an invaluable partner, and his support has been instrumental to our success in Bulgaria.
- The Boyanov team supporting us in Bulgaria distinguishes itself through a combination of deep local expertise, proactive client service, and a forward-thinking approach to legal practice. Their thorough understanding of the regulatory landscape, coupled with a strong commitment to collaboration, allows them to deliver practical and effective solutions tailored to our business objectives. One of the practice’s key strengths is its responsiveness and ability to address complex issues swiftly and efficiently. The team is highly accessible, consistently providing clear and actionable guidance, which sets them apart from other firms. Their willingness to adapt to client needs—whether through innovative billing structures, the use of advanced legal technology, or a flexible approach to project management—demonstrates a genuine focus on adding value.
- 'The team is very professional and have high knowledge on all the areas of law, which is very important for an international company having presence in Bulgaria.'
- 'Peter Petrov is one of the best lawyers that our company cooperates with amongst different countries. He is very knowledgeable and always helps the customer.'
Key clients
- Neola Pharma EOOD
- F. Hoffmann La Roche
- AbbVie
- ARPharM Bulgaria
- Bayer
- Novartis
- GSK
- Celgene Corporation
- Merck
- Medtronic
- Pfizer
- Anika Therapeutics
Work highlights
Advising the Association of Research-Based Pharmaceutical Manufacturers in Bulgaria on various legal aspects of the Bulgarian pharmaceutical claw-back mechanism system.
Advised and represented Bayer AG on a number of patent-related market entry regulatory issues in relation to one of its key products.
Advised Sopharma AD in completing the initial stage of its strategic pharmaceutical portfolio acquisition in several Eastern Europe jurisdictions.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Nedyalka Novakova
Practice head
Kina Chuturkova; Peter Petrov
Other key lawyers
Nedyalka Novakova